Evidence map›Paper›PMID 40091520›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

ADAR1-HNRNPL-Mediated CircCANX Decline Promotes Autophagy in Chronic Obstructive Pulmonary Disease.

Ting-Ting Chen, Yuan-Yuan Wei, Jia-Ying Kang, Da-Wei Zhang, Jing-Jing Ye, Xi-Shi Sun, Mei Hong, Wen-Ting Zhang, Hui-Mei Wu, Zhen-Xing Ding and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ting-Ting ChenDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, 230022, China.
Yuan-Yuan WeiDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, 230022, China.
Jia-Ying KangDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, 230022, China.
Da-Wei ZhangDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, 230022, China.
Jing-Jing YeDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, 230022, China.
Xi-Shi SunEmergency Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong Province, 524000, China.
Mei HongDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, 230022, China.
Wen-Ting ZhangDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, 230022, China.
Hui-Mei WuDepartment of Geriatric Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, 230022, China.
Zhen-Xing DingDepartment of Emergency Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, 230022, China.
Guang-He FeiDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, 230022, China.ORCID https://orcid.org/0000-0003-0064-2073

Funding

Anhui Province Clinical Medical Research Transformation Project 202304295107020038Anhui University Excellent Research and Innovation Team Plan 2023AH010082National Natural Science Foundation of China 82170050National Natural Science Foundation of China 82470034
6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a characteristic chronic airway inflammatory disease that worsens over time, however, there are currently limited clinical therapeutics to suspend its progression. Circular RNAs (circRNAs), which have emerged as functional regulators in various diseases, including COPD, may server as new pharmacological targets in COPD. Here, it is identified a nuclear circRNA, circCANX, that is preferentially decreased in COPD. The linear splicing of CANX pre-mRNA, enhanced by the ADAR1-HNRNPL interaction, is responsible for the circCANX decline. Clinically, the higher circCANX expression is associated with a worse lung function index of FEV

Indexed as

Adenosine DeaminaseAutophagyPulmonary Disease, Chronic ObstructiveRNA-Binding ProteinsRNA, CircularAnimalsFemaleHumansMaleMiceADAR protein, humanAdenosine DeaminaseRNA-Binding ProteinsRNA, Circularautophagychronic obstructive pulmonary diseaseCircCANXCircRNA biogenesisnonsense‐mediated mRNA decaystress granule

Identifiers

PMID40091520
PMCPMC12079403

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.